(Q40916414)

24 September 2017

Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas (English)

1 reference

24 September 2017

Sasaki M

1

1 reference

24 September 2017

Wizigmann-Voos S

series ordinal

2

1 reference

24 September 2017

Risau W

series ordinal

3

1 reference

24 September 2017

Plate KH

series ordinal

4

1 reference

24 September 2017

1 August 1999

1 reference

International Journal of Developmental Neuroscience

24 September 2017

1 reference

24 September 2017

17

1 reference

24 September 2017

5-6

1 reference

24 September 2017

579-591

1 reference

Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Gene therapy strategies for tumor antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Gene therapy for brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

A safe packaging line for gene transfer: separating viral genes on two different plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Gene therapy of malignant glioma via inhibition of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Angiogenesis in malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Gene therapy of malignant glioma: recent advances in experimental and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900053-2

7 January 2021

10.1016/S0736-5748(99)00053-2

Identifiers

DOI

1 reference

24 September 2017

1 reference